Founder & Principal
Jeffrey Carr
Life-sciences manufacturing, MSAT, technology transfer, operational readiness, and technical leadership.
Jeffrey founded JMC Life Sciences to help organizations solve the difficult translation problem between scientific development and dependable manufacturing execution.
Professional profile
Technical depth. Operational perspective. Cross-modality experience.
Jeffrey Carr is a life-sciences manufacturing, MSAT, and technical operations leader with experience translating complex bioprocesses into executable manufacturing strategies. His career has spanned advanced therapies, biologics, technology transfer, facility and site readiness, engineering execution, process troubleshooting, validation, technical documentation, and cross-functional manufacturing support.
His technical experience includes T cells, NK cells, mesenchymal stromal cells (MSCs), hematopoietic stem cells (HSCs), corneal endothelial cells, and monoclonal antibodies (mAbs). Across these modalities, he has worked at the intersection of process science and manufacturing execution—helping teams assess process risk, integrate equipment and materials, prepare facilities and personnel, transfer technical knowledge, troubleshoot manufacturing challenges, and strengthen GMP execution.
Jeffrey has also supported manufacturing readiness, engineering campaigns, investigations and CAPA, process validation, and late-stage manufacturing preparation. Across those programs, one challenge remains consistent: turning scientific intent into a process that manufacturing teams can perform reliably, repeatably, and with confidence. That translation is the foundation of JMC Life Sciences.
Selected Technical Experience
Breadth across cell therapies, biologics, and manufacturing execution
Cell & Gene Therapy
T Cells • NK Cells • HSCs
Regenerative & Cell-Based Therapies
MSCs • Corneal Endothelial Cells
Biologics
Monoclonal Antibodies (mAbs)
Manufacturing & Technical Operations
MSAT • Technology Transfer • Engineering Runs • GMP Readiness • Process Validation • Investigations & CAPA
MSAT & Technical Operations
Led and supported manufacturing-science work focused on process understanding, technical risk, floor support, investigations, deviations, CAPA, process performance, and data-driven decision-making.
Technology Transfer
Built transfer strategies, technical packages, process comparisons, readiness plans, manufacturing records, BOMs, equipment lists, sampling strategies, and engineering-run approaches.
Facility & Site Readiness
Supported manufacturing facility build-out and start-up in the Houston/Woodlands area, including procedures, policies, site readiness, equipment integration, and operating-system development.
Advanced Therapies & Biologics
Worked across programs involving T cells, NK cells, MSCs, HSCs, corneal endothelial cells, and monoclonal antibodies, with experience spanning cell expansion, cryopreservation, aseptic processing, process integration, and manufacturing execution.
Process Troubleshooting
Investigated difficult execution and performance problems including cryopreservation-related decline, material and handling effects, cell-culture variability, equipment/process interactions, RNP precipitation, and scale-related dependencies.
Engineering & Readiness Runs
Planned and supported training and engineering runs, go/no-go readiness, production-intent equipment use, operator preparation, process lock decisions, and cross-functional issue resolution.
How Jeffrey leads
Execution is technical. It is also deeply human.
Jeffrey’s leadership approach is grounded in clarity, accountability, and developing people. His background in both technical operations and pastoral leadership shaped a style that takes process discipline seriously without losing sight of the people doing the work.
That perspective informs how JMC approaches consulting: understand the science, build the system, equip the team, and make the path to execution unmistakably clear.
Work with JMC
JMC Life Sciences LLC 